This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Università Degli Studi Di Firenze. Active years: 2014.
Company Filing History:
Years Active: 2014
Title: Lido Calorini: Innovator in Peptidomimetic Integrin Inhibitors
Introduction
Lido Calorini is a distinguished inventor based in Florence, Italy. He has made significant contributions to the field of chemical compounds, particularly in the development of innovative therapeutic solutions for various medical conditions.
Latest Patents
Calorini holds a patent for "1,2,3-triazole-based peptidomimetic integrin inhibitors for the diagnosis and therapy of tumors." This invention pertains to chemical compounds featuring a 1,2,3-triazole ring and possessing guanidino and carboxylic groups or their isosteres. The preparation of these compounds is achieved through Cu-catalyzed 'click-chemistry.' The medical-diagnostic applications of this invention are particularly relevant in pathologies where angiogenesis is altered, such as tumor-related conditions, tumor metastasis, osteoporosis, and rheumatoid arthritis. He has been granted 1 patent for this groundbreaking work.
Career Highlights
Calorini is affiliated with the Università Degli Studi Di Firenze, where he continues to engage in research and development in the field of chemical compounds and their medical applications. His work has garnered attention for its potential impact on cancer therapy and other related medical fields.
Collaborations
Throughout his career, Calorini has collaborated with notable colleagues, including Antonio Guarna and Gloria Menchi. These partnerships have contributed to the advancement of his research and the successful development of his patented inventions.
Conclusion
Lido Calorini is a prominent figure in the realm of chemical innovation, particularly in the development of peptidomimetic integrin inhibitors. His contributions have the potential to significantly impact the diagnosis and treatment of various medical conditions.